No results for ‘’
Themis Medicare Ltd
₹101.73
(0.08%)
Mon, 29 Jun 2026, 06:58 am
Health Technology
Pharmaceuticals: Major
24.5KThemis Medicare Price to Cash Flow Ratio
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 38.26 | 13.16 | 6.82 | 0 | 7.75 | 15.75 | 0 | 0 | 20.83 | 23.62 | 18.83 | 34.90 | 45.30 | 0 | 8.90 | 7.22 | 11.80 | 18.90 | 46.40 | 45.33 |
| Price to book ratio | 3.19 | 1.64 | 1.46 | 0.49 | 1.92 | 1.77 | 1.24 | 0.79 | 0.87 | 1.98 | 4.11 | 3.65 | 3.02 | 1.72 | 1.20 | 1.18 | 2.99 | 3.16 | 5.34 | 3.35 |
| Price to sales ratio | 1.64 | 0.66 | 0.52 | 0.21 | 0.70 | 0.64 | 0.53 | 0.25 | 0.26 | 0.59 | 1.32 | 2.57 | 2.44 | 1.48 | 1.09 | 1.12 | 2.18 | 3.03 | 5.29 | 3.33 |
| Price to cash flow ratio | 80.35 | 14.88 | 0 | 0 | 33.82 | 30.92 | 0 | 7.55 | 7.15 | 6.21 | 11.11 | 0 | 0 | 177.30 | 0 | 4.95 | 26.73 | 82.88 | 101.24 | 54.82 |
| Enterprise value | 225Cr | 150Cr | 217Cr | 157Cr | 269Cr | 277Cr | 215Cr | 186Cr | 192Cr | 250Cr | 420Cr | 630Cr | 585Cr | 351Cr | 315Cr | 321Cr | 913Cr | 1149Cr | 2096Cr | 1422Cr |
| Enterprise value to EBITDA ratio | 222.17 | 7.84 | 6.97 | 12.75 | 8.39 | 13.44 | 0 | 15.11 | 9.75 | 14.14 | 11.01 | 19.01 | 23.22 | 152.76 | 8.82 | 6.48 | 9.55 | 17.03 | 40.69 | 28.98 |
| Debt to equity ratio | 0.78 | 0.78 | 1.35 | 1.38 | 1.48 | 1.36 | 2.59 | 2.90 | 2.67 | 2.38 | 1.73 | 0.54 | 0.47 | 0.52 | 0.55 | 0.40 | 0.28 | 0.27 | 0.25 | 0.21 |
| Return on equity % | 0 | 12.96 | 23.69 | -12.62 | 23.56 | 11.45 | -45.32 | -8.54 | 4.27 | 8.70 | 24.49 | 14.09 | 7.03 | -6.57 | 14.53 | 17.78 | 28.81 | 18.15 | 12.14 | 7.65 |
Themis Medicare Ltd Price to Cash Flow Ratio
The Themis Medicare Ltd Price to Cash Flow Ratio is a key financial metric used by investors to evaluate Themis Medicare Ltd's valuation, profitability, and overall financial performance. Tracking the Themis Medicare Ltd Price to Cash Flow Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Themis Medicare Ltd (NSE: THEMISMED, BSE: 530199) is currently trading at ₹101.73, with a market capitalization of ₹939.42Cr. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Themis Medicare Ltd Price to Cash Flow Ratio is essential for fundamental analysis.
Themis Medicare Ltd Price to Cash Flow Ratio Current Value
The current Themis Medicare Ltd Price to Cash Flow Ratio stands at 54.82.
The Themis Medicare Ltd Price to Cash Flow Ratio has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Themis Medicare Ltd Price to Cash Flow Ratio Historical Trend
The Themis Medicare Ltd Price to Cash Flow Ratio has shown the following historical trend:
- 2024: 54.82
- 2023: 101.24
- 2022: 82.88
- 2021: 26.73
- 2020: 4.95
The decline in Themis Medicare Ltd Price to Cash Flow Ratio indicates improving financial efficiency or better earnings growth.
What Themis Medicare Ltd Price to Cash Flow Ratio Indicates for Investors
The Themis Medicare Ltd Price to Cash Flow Ratio plays a crucial role in understanding the company's financial health and valuation.
The P/CF ratio indicates how much investors pay for company cash flow.
Themis Medicare Ltd Price to Cash Flow Ratio Analysis Summary
The Themis Medicare Ltd Price to Cash Flow Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Themis Medicare Ltd Price to Cash Flow Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Themis Medicare Ltd Price to Cash Flow Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.